TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A Phase III clinical trial published in JAMA Pediatrics found that 38% silver diamine fluoride, applied every six months, stopped decay in more than half of treated baby teeth among children younger than 6. The liquid does not restore lost tooth structure, and it permanently darkens the decayed area; researchers say the U.S. trial adds evidence for a treatment dentists have used for decades.
A Phase III clinical trial involving 830 children younger than 6 found that applying 38% silver diamine fluoride (SDF) every six months stopped decay in more than half of the treated baby teeth. Published in JAMA Pediatrics, the University of Michigan-led study adds U.S. clinical evidence for a quick, non-drilling option that may help manage cavities in young children, though it does not replace tooth structure lost to decay.
In the trial, children were recruited through dental clinics, pediatric medical practices, and Head Start and Early Head Start programs in Michigan, New York and Iowa. The treatment was applied to affected teeth at six-month intervals. Researchers reported that decay was arrested in more than half of those teeth. In dental terminology, arrest means the existing decay stops progressing; it does not mean that the damaged area is rebuilt or that a conventional filling has been placed.
SDF is applied directly to a cavity with a small applicator, a process described as taking seconds per tooth. Unlike a filling procedure, it does not require drilling, injections or sedation. The solution combines silver, which helps combat bacteria associated with decay, and fluoride, which supports tooth mineral and resistance to further damage. The trial report describes the treatment as a way to manage decay, not as a guarantee that every cavity will stop or that follow-up care will not be needed.
The study’s lead investigator, Margherita Fontana, a University of Michigan dentistry professor, said the findings support the treatment’s use in young children. The report also identifies a clear drawback: SDF permanently darkens the decayed portion of a treated tooth. The discoloration is cosmetic, but may be conspicuous on front teeth and could affect whether a family chooses the approach.
A Non-Drilling Option for Young Children
The findings matter because cavities in young children can be difficult to treat with conventional procedures. Some children may struggle to stay still or feel significant anxiety, while extensive treatment can require surgery under general anesthesia. A brief application that arrests decay could give families and clinicians another way to manage some cavities, particularly when a child cannot readily undergo a filling procedure.
The public-health implications are also relevant in the United States, where the source report says tooth decay affects more than 40% of children. Untreated cavities can progress to pain, infection and difficulties eating or sleeping. The report notes that children with untreated decay may visit emergency departments, where clinicians generally cannot perform the dental procedures needed to address the underlying problem. SDF could help some patients avoid progression while they seek ongoing dental care, but the trial does not establish that it will prevent every emergency visit or eliminate the need for dental treatment.
The treatment’s fast application may also be useful for patients who have difficulty accessing or tolerating conventional dentistry, including some older adults and people with disabilities or severe dental anxiety. Those broader potential uses are not the same as results demonstrated in this trial, which enrolled children under 6. Whether use expands will depend on clinical guidance, regulatory developments, access and patient acceptance of the staining tradeoff.
Products Worth Considering
Weber Searwood 600 Wood Pellet Smoker Grill, Black
AMERLIFE 34 x 10 x 7 ft Walk-In Tunnel Greenhouse with Watering System
EGO Power+ 16 Cordless Chainsaw (CS1611) with 56V 2.5Ah Battery and Charger
As an affiliate, we earn on qualifying purchases.
Why U.S. Trial Evidence Matters
Silver diamine fluoride is not new. Dentists in several countries have used it to manage cavities for decades. In the United States, the FDA approved SDF in 2014 as a medical device for treating tooth sensitivity. Dentists have also used it off-label to arrest cavities, meaning the product is used for a purpose beyond its original authorized indication.
The University of Michigan-led researchers designed the Phase III trial to add large-scale evidence from U.S. populations about SDF’s safety and effectiveness for decay. The study began in 2018 and continued through disruptions caused by the COVID-19 pandemic. That evidence may inform discussions about wider use, including whether pediatric medical settings could apply the treatment or connect families with dental care. The trial’s results alone do not amount to FDA approval for cavity treatment.
Limits, Staining and Approval Status
The reported result is that decay stopped in more than half of affected baby teeth when SDF was applied every six months. The source material does not provide the precise arrest rate, follow-up duration, comparisons between treatment groups, or detailed adverse-event figures, so those details cannot be assessed here. The finding should not be interpreted as a cure for all cavities or as evidence that SDF restores damaged tooth structure.
It is also not clear from the report whether the trial findings will lead to a change in FDA authorization for cavity treatment or to new clinical recommendations. In the U.S., the product’s stated FDA approval is for tooth sensitivity; cavity use has been off-label. Permanent dark staining of the treated decay remains a practical concern, especially on visible teeth, and families may weigh that against avoiding drilling or more invasive treatment.
Next Steps for Wider Dental Use
The study’s publication gives dental and medical professionals U.S. trial results to review, but adoption will depend on how researchers, professional organizations and regulators assess the evidence. The report does not identify a specific date for an FDA decision or a new national guideline. Any broader use in pediatric medical settings would also require a practical pathway for consent, application and follow-up with dental care.
For families, the immediate implication is that SDF may be an option to discuss with a qualified dental professional when a young child has a cavity. The clinician can explain whether it fits the child’s situation, the likelihood of staining, and what monitoring or further treatment may be needed. The trial supports SDF as a way to arrest many treated cavities, not as a substitute for individualized dental care.
Key Questions
What is silver diamine fluoride?
Silver diamine fluoride is a liquid applied directly to a tooth affected by decay. Its silver component helps combat decay-associated bacteria, while fluoride supports tooth mineral. In this trial, the solution contained 38% SDF.
Does SDF fill or repair a cavity?
No. The study describes SDF as a way to arrest decay, meaning the damaged area stops deteriorating. It does not replace the tooth structure already lost, as a filling does.
How often was the treatment applied in the study?
Children received treatment at six-month intervals. The trial found that decay stopped in more than half of the affected baby teeth treated this way.
What is the main drawback of SDF?
SDF permanently darkens the decayed portion of the treated tooth. The staining is cosmetic, but may be noticeable on front teeth and can influence a family’s decision.
Is SDF approved in the United States to treat cavities?
According to the report, the FDA approved SDF in 2014 as a medical device for tooth sensitivity. Dentists have used it off-label to arrest cavities; the trial report does not say that the FDA has approved it specifically for cavity treatment.
Source: sciencedaily.com
